Atlas Capital Advisors LLC Merck & Co., Inc. Transaction History

Atlas Capital Advisors LLC

  • $640 Billion
  • Q1 2024

A detailed history of Atlas Capital Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 4,470 shares of MRK stock, worth $562,549. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,470
Previous 5,205 14.12%
Holding current value
$562,549
Previous $567 Million 3.94%
% of portfolio
0.09%
Previous 0.08%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
SELL
$113.24 - $131.95 $83,231 - $96,983
-735 Reduced 14.12%
4,470 $590 Million
Q4 2023

Feb 15, 2024
SELL
$100.18 - $109.02 $127,829 - $139,109
-1,276 Reduced 19.69%
5,205 $567 Million
Q3 2023

Nov 14, 2023
SELL
$102.95 - $114.33 $14,001 - $15,548
-136 Reduced 2.06%
6,481 $667 Million
Q2 2023

Aug 15, 2023
SELL
$108.61 - $118.38 $51,046 - $55,638
-470 Reduced 6.63%
6,617 $764 Million
Q1 2023

May 16, 2023
SELL
$102.94 - $114.86 $345,775 - $385,814
-3,359 Reduced 32.16%
7,087 $754 Million
Q4 2022

Feb 15, 2023
BUY
$87.44 - $112.11 $348,098 - $446,309
3,981 Added 61.58%
10,446 $1.16 Billion
Q3 2022

Nov 08, 2022
BUY
$84.53 - $94.96 $11,665 - $13,104
138 Added 2.18%
6,465 $557 Million
Q2 2022

Aug 16, 2022
SELL
$83.49 - $94.64 $115,884 - $131,360
-1,388 Reduced 17.99%
6,327 $577 Million
Q1 2022

May 11, 2022
BUY
$73.51 - $82.4 $106,221 - $119,068
1,445 Added 23.05%
7,715 $633 Million
Q4 2021

Feb 01, 2022
BUY
$72.28 - $90.54 $159,955 - $200,365
2,213 Added 54.55%
6,270 $481 Million
Q2 2021

Jul 30, 2021
BUY
$70.31 - $77.77 $110,316 - $122,021
1,569 Added 63.06%
4,057 $315,000
Q4 2020

Feb 16, 2021
BUY
$71.77 - $79.65 $178,563 - $198,169
2,488 New
2,488 $194,000
Q3 2020

Oct 23, 2020
SELL
$73.18 - $82.95 $182,071 - $206,379
-2,488 Closed
0 $0
Q2 2020

Jul 28, 2020
SELL
$70.42 - $80.13 $70,420 - $80,130
-1,000 Reduced 28.67%
2,488 $183,000
Q1 2020

May 04, 2020
SELL
$63.36 - $87.82 $14,636 - $20,286
-231 Reduced 6.21%
3,488 $256,000
Q4 2019

Jan 28, 2020
SELL
$77.58 - $87.54 $6,051 - $6,828
-78 Reduced 2.05%
3,719 $322,000
Q3 2019

Nov 01, 2019
BUY
$76.08 - $82.93 $21,454 - $23,386
282 Added 8.02%
3,797 $304,000
Q2 2019

Jul 25, 2019
BUY
$69.84 - $81.59 $141,984 - $165,872
2,033 Added 137.18%
3,515 $0
Q1 2019

Apr 29, 2019
SELL
$69.58 - $79.36 $3,200 - $3,650
-46 Reduced 3.01%
1,482 $0
Q4 2018

Jan 29, 2019
BUY
$65.24 - $75.71 $9,981 - $11,583
153 Added 11.13%
1,528 $111,000
Q3 2018

Nov 09, 2018
BUY
$57.69 - $67.84 $11,653 - $13,703
202 Added 17.22%
1,375 $0
Q1 2018

Apr 18, 2018
BUY
$50.96 - $59.23 $59,776 - $69,476
1,173 New
1,173 $0

Others Institutions Holding MRK

# of Institutions
3,768
Shares Held
1.87B
Call Options Held
17.3M
Put Options Held
14.8M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email